Abstract
A medical condition producing excessive thirst, continuous urination, and severe weight loss has interested medical authors for over three millennia. Unfortunately, until the early part of the twentieth century the prognosis for a patient with this condition was no better than it was over 3000 years ago. Since the ancient physicians described almost exclusively cases of what is known today as type 1 diabetes mellitus, the outcome was invariably fatal.
Similar content being viewed by others
References
Papaspyros NS. The history of diabetes. In: Verlag GT, editor. The history of diabetes mellitus. Stuttgart: Thieme; 1964. p. 4.
http://www.crystalinks.com/egyptmedicine.html – ancient Egyptian medicine, Ebers papyrus.
Medvei VC. The Greco – Roman period. In: Medvei VC, editor. The history of clinical endocrinology: a comprehensive account of endocrinology from earliest times to the present day. New York: Parthenon Publishing; 1993. p. 34–7.
Southgate TM. De medicina. JAMA. 1999;10:921.
Sanders LJ. From Thebes to Toronto and the 21st century: an incredible journey. Diabetes Spect. 2002;15:56–60.
Medvei VC. Mediaeval scene. In: Medvei VC, editor. The history of clinical endocrinology: a comprehensive account of endocrinology from earliest times to the present day. New York: Parthenon Publishing; 1993. p. 46–9.
Medvei VC. The 16th century and the renaissance. In: Medvei VC, editor. The history of clinical endocrinology: a comprehensive account of endocrinology from earliest times to the present day. New York: Parthenon Publishing; 1993. p. 55–6.
Medvei VC. The 18th century and the beginning of the 19th century. In: Medvei VC, editor. The history of clinical endocrinology: a comprehensive account of endocrinology from earliest Times to the present day. New York: Parthenon Publishing; 1993. p. 97.
www.uic.edu – Claude Bernard.
www.britannica.com – Claude Bernard.
Medvei VC. Story of insulin. In: Medvei VC, editor. The history of clinical endocrinology: a comprehensive account of endocrinology from earliest times to the present day. New York: Parthenon Publishing; 1993. p. 249–51.
Schullian DM. John Rollo’s patient. J Hist Med. 1965;2:163–4.
Bliss M. A long prelude. In: Bliss M, editor. The discovery of insulin. Chicago: The University of Chicago Press; 1982. p. 33–9.
Minkowski O. Introduction and translation by R. Levine. Historical development of the theory of pancreatic diabetes. Diabetes. 1989;38:1–6.
Medvei VC. The birth of endocrinology. In: Medvei VC, editor. The history of clinical endocrinology: a comprehensive account of endocrinology from earliest times to the present day. New York: Parthenon Publishing; 1993. p. 151.
Bliss M. Banting’s idea. In: Bliss M, editor. The discovery of insulin. Chicago: University of Chicago Press; 2007. p. 45–58.
Bliss M. A mysterious something. In: Bliss M, editor. The discovery of insulin. Chicago: University of Chicago Press; 2007. p. 84–103.
Bliss M. Triumph. In: Bliss M, editor. The discovery of insulin. Chicago: University of Chicago Press; 1982. p. 104–28.
MacCracken J. From ants to analogues. Puzzles and promises in diabetes management. Postgrad Med. 1997;4:138–50.
Pratt P. History of insulin. Hutchinson family encyclopedia. Online edition. Oxford: Helicon Publishing; 2000.
Born DM. The journey and the dream: a history of the American Diabetes Association. Alexandria: American Diabetes Association; 1990. p. 1–14.
www.nobel.se – August Krogh.
Medvei VC. Present trends and outlook for the future – part III. In: Medvei VC, editor. The history of clinical endocrinology: a comprehensive account of endocrinology from earliest times to the present day. New York: Parthenon Publishing; 1993. p. 380–3.
Segre GV, Brown EN. Measurement of hormones. In: Wilson JD, Foster DW, Kronenberg HM, Larsen PR, editors. Williams textbook of endocrinology. 9th ed. Philadelphia: WB Saunders; 1998. p. 44–5.
Medvei VC. Chronological tables. In: Medvei VC, editor. The history of clinical endocrinology: a comprehensive account of endocrinology from earliest times to the present day. New York: Parthenon Publishing; 1993. p. 495.
www.gene.com – press release 6 Sept 1978.
Galloway J, DeShazo R. Insulin chemistry and pharmacology: insulin allergy, resistance, and lipodystrophy. In: Rifkin H, Porte Jr D, editors. Diabetes mellitus. Theory and practice. 4th ed. New York: Elsevier; 1990. p. 498.
Blevins TC, et al. Statement by the American Association of Clinical Endocrinologists Consensus panel on continuous glucose monitoring. Endocr Pract. 2010;16(5):730–45.
Holmquist WR, Schroeder WA. A new N-terminal blocking group involving a Schiff base in hemoglobin A1c. Biochemistry. 1966;5:2489–503.
Bookchin RM, Gallop PM. Structure of hemoglobin A1c: nature of the N-terminal β chain blocking group. Biochem Biophys Res Commun. 1968;32:86–93.
Samuel R. An abnormal hemoglobin in red cells of diabetics. Clin Chim Acta. 1968;22:296–8.
Rahbar S, Blumenfeld O, Ranney HM. Studies of an unusual hemoglobin in patients with diabetes mellitus. Biochem Biophys Res Commun. 1969;36:838–43.
Tattersall RB, Pyke DA, Ranney HM, Bruckheimer SM. Hemoglobin components in diabetes mellitus: studies in identical twins. N Engl J Med. 1975;293:1171–3.
Koenig RJ, Peterson CM, Jones RL, Saudek C, Lehrman M, Cermani A. Correlation of glucose regulation and hemoglobin A1c in diabetes mellitus. N Engl J Med. 1976;295:417–20.
The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–86.
The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med. 2000;342:381–9.
The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353:2643–53.
UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylurea or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–53.
UK Prospective Diabetes Study Group. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ. 2000;321:412–9.
UK Prospective Diabetes Study Group. Effects of intensive blood-glucose control with metformin on complications in overweight patients with type 2 Diabetes (UKPDS 34). Lancet. 1998;325:854–65.
Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial. NIH: National Heart, Lung, and Blood. Updated March 14, 2010. https://www.nhlbi.nih.gov/health-pro/resources/heart/accord-trial. Accessed 26 Sept 2015.
The Look AHEAD Research Group. The Look AHEAD study: a description of the lifestyle intervention and the evidence supporting it. Obesity. 2006;14:737–52.
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes: the Look AHEAD Research Group. N Engl J Med. 2013. doi: 10.1056/NEJMoa1212914.
Gruessner RWG, Sutherland D, Kandaswamy R, et al. Lessons learned from >500 pancreas transplants alone at a single institution. Am J Transplant. 2007;7:249.
Lacy PE, Kostianovsky M. Methods for the isolation of intact islets of Langerhans from rat pancreas. Diabetes. 1967;16:35–9.
Wahoff DC, Papalois BE, Najarian JS, et al. Autologous islet cell transplant to prevent diabetes after pancreatic resection. Ann Surg. 1995;222:562–79.
Shapiro JAM, Lakey JRT, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med. 2000;343:230–8.
Ryan EA, Paty BW, Senior PA, et al. Five-year follow-up after clinical islet transplantation. Diabetes. 2005;54:2060–8.
Matsumoto S. Clinical allogeneic and autologous islet cell transplantation: update. Diabetes Metab J. 2011;35(3):199–206. doi:10.4093/dmj.2011.35.3.199.
Artificial Pancreas Project Research: Artificial Pancreas Project Plan. Juvenile Diabetes Research Foundation. JDRF 2015. http://jdrf.org/research/treat/artificial-pancreas-project/. Accessed 23 Aug 2015.
Clinical Studies and the Development of the Artificial Pancreas. U.S. Food and Drug Administration. U.S. Department of Health and Human Sevices. 2014. http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/HomeHealthandConsumer/ConsumerProducts/ArtificialPancreas/ucm259568.htm. Accessed 23 Aug 2015
Russell SJ, et al. Outpatient glycemic control with a bionic pancreas in type 1 diabetes. N Engl J Med. 2014;371:313–25. doi: 10.1056/NEJMoa1314474.
Overweight and obesity statistics. National Institute of Diabetes and Digestive and Kidney Diseases. U.S. Department of Health and Human Services. Updated Oct 2012. http://www.niddk.nih.gov/health-information/health-statistics/Pages/overweight-obesity-statistics.aspx. Accessed 26 Sept 2015.
Cefalu WT, Bray GA, Home PD, et al. Advances in the science, treatment, and prevention of the disease of obesity: reflections from a diabetes care editors’ expert forum. Diabetes Care. 2015;38:1567–82. doi:10.2337/dc15-1081.
Morbidity and Mortality Weekly Report. Center of diabetes control and prevention. MMWR. 2004;53:80–2.
Manson JE, Rimm EB, Stampfer MJ, et al. A prospective study of physical activity and incidence of non insulin-dependent diabetes mellitus in women. Lancet. 1991;338:774–7.
U.S. Department of Health and Human Services. Healthy people 2000: summary report. Washington, DC: U.S. Department of Health and Human Services (DHHS Publ. PHSSs 91–50213); 1992. p. 6–8, 55, 91–2.
Tuomilehto J, Lindstrom J, Eriksson JG, Finnish Diabetes Prevention Study Group, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343–50.
Pan XR, Li GW, Wang JX, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20:537–44.
Helmrich SP, Ragland DR, Leung RW, Paffenbarger RS. Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. N Engl J Med. 1991;325:147–52.
www.niddk.nih.gov – results of Diabetes Prevention Program, Diabetes Prevention Trial.
Diabetes Prevention Trial – Type 1 Diabetes Group. Effects of insulin in relatives of patients with type 1 diabetes mellitus. N Engl J Med. 2002;346:1685–91.
Diabetes Prevention Trial – Type 1 Diabetes Group. Effects of oral insulin in relatives of patients with type 1 diabetes. Diabetes Care. 2005;28:1068–76.
Fowler, G. Dr. Ora M. Rosen, 55, scientist: studied the development of cells. The New York Times. 1 June 1990.
Rosen OM. After insulin binds. Science. 1987;237:1452–8. doi:10.1126/science.2442814.
Scott LJ, Mohlke KL, Bonnycastle LL, et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science. 2007;316:1341–5.
Saxena R, Voight BF, Lyssenko V, et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science. 2007;316:1331–6.
Zeggini E, Weedon MN, Lindgren CM, McCarthy MI, Hattersley AT. Replications of genome wide association signals in UIC sample reval risk loci for type Z diabetes. The Welcome Trust Case Control Consortium (WTCCC), et al. Science. 2007;316:1336–41.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this entry
Cite this entry
Goldman, R., Zajac, J., Shrestha, A., Patel, P., Poretsky, L. (2015). The Main Events in the History of Diabetes Mellitus. In: Poretsky, L. (eds) Principles of Diabetes Mellitus. Springer, Cham. https://doi.org/10.1007/978-3-319-20797-1_1-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-20797-1_1-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Online ISBN: 978-3-319-20797-1
eBook Packages: Springer Reference MedicineReference Module Medicine